Natixis Advisors’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$95.6M Sell
402,374
-90,458
-18% -$18.8M 0.11% 180
2026
Q1
$104M Sell
492,832
-28,419
-5% -$6.12M 0.14% 153
2025
Q4
$107M Buy
521,251
+85,590
+20% +$16.1M 0.15% 143
2025
Q3
$68.4M Sell
435,661
-84,230
-16% -$13M 0.1% 199
2025
Q2
$87.3M Sell
519,891
-9,940
-2% -$1.48M 0.14% 165
2025
Q1
$73M Buy
529,831
+22,453
+4% +$2.86M 0.13% 168
2024
Q4
$60M Buy
507,378
+45,929
+10% +$5.36M 0.11% 185
2024
Q3
$51M Buy
461,449
+85,029
+23% +$8.89M 0.1% 209
2024
Q2
$37M Buy
376,420
+21,022
+6% +$2.14M 0.08% 242
2024
Q1
$39.8M Buy
355,398
+14,244
+4% +$1.54M 0.09% 226
2023
Q4
$34.4M Buy
341,154
+19,630
+6% +$1.95M 0.09% 240
2023
Q3
$27.9M Buy
321,524
+33,043
+11% +$2.99M 0.09% 251
2023
Q2
$27.3M Buy
288,481
+44,762
+18% +$3.78M 0.08% 247
2023
Q1
$18.4M Buy
243,719
+3,279
+1% +$247K 0.06% 317
2022
Q4
$18.5M Buy
240,440
+31,835
+15% +$2.42M 0.07% 317
2022
Q3
$13.9M Buy
208,605
+102,625
+97% +$6.51M 0.06% 353
2022
Q2
$5.54M Buy
105,980
+26,835
+34% +$1.53M 0.02% 617
2022
Q1
$4.49M Buy
79,145
+7,176
+10% +$384K 0.02% 714
2021
Q4
$3.71M Sell
71,969
-11,823
-14% -$580K 0.01% 775
2021
Q3
$4.14M Buy
83,792
+14,354
+21% +$779K 0.02% 701
2021
Q2
$3.96M Buy
69,438
+7,756
+13% +$453K 0.02% 704
2021
Q1
$3.75M Buy
61,682
+14,655
+31% +$809K 0.02% 688
2020
Q4
$2.52M Buy
47,027
+3,624
+8% +$188K 0.01% 768
2020
Q3
$2.04M Buy
43,403
+3,847
+10% +$197K 0.01% 788
2020
Q2
$2.06M Sell
39,556
-3,600
-8% -$186K 0.01% 793
2020
Q1
$2.07M Sell
43,156
-52,594
-55% -$2.73M 0.02% 726
2019
Q4
$4.84M Buy
95,750
+14,280
+18% +$738K 0.03% 539
2019
Q3
$3.85M Buy
81,470
+20,289
+33% +$926K 0.03% 572
2019
Q2
$2.88M Buy
61,181
+3,999
+7% +$184K 0.02% 655
2019
Q1
$2.75M Sell
57,182
-6,734
-11% -$337K 0.02% 648
2018
Q4
$2.85M Sell
63,916
-22,711
-26% -$1.18M 0.03% 579
2018
Q3
$4.68M Sell
86,627
-11,631
-12% -$595K 0.04% 493
2018
Q2
$4.8M Buy
98,258
+6,003
+7% +$340K 0.05% 474
2018
Q1
$5.78M Buy
92,255
+35,173
+62% +$2.41M 0.06% 388
2017
Q4
$3.5M Sell
57,082
-3,701
-6% -$229K 0.04% 531
2017
Q3
$4.07M Sell
60,783
-622
-1% -$44K 0.04% 496
2017
Q2
$4.79M Sell
61,405
-8,128
-12% -$613K 0.05% 436
2017
Q1
$5.67M Sell
69,533
-2,802
-4% -$221K 0.06% 385
2016
Q4
$5.21M Sell
72,335
-13,670
-16% -$988K 0.06% 393
2016
Q3
$6.68M Sell
86,005
-1,931
-2% -$156K 0.09% 285
2016
Q2
$6.86M Buy
87,936
+3,301
+4% +$263K 0.09% 264
2016
Q1
$6.93M Buy
84,635
+52,815
+166% +$4.29M 0.1% 238
2015
Q4
$2.84M Buy
31,820
+5,188
+19% +$441K 0.05% 503
2015
Q3
$2.04M Sell
26,632
-4,315
-14% -$361K 0.04% 596
2015
Q2
$2.59M Buy
30,947
+8,572
+38% +$757K 0.04% 543
2015
Q1
$2.02M Buy
22,375
+4,562
+26% +$393K 0.04% 618
2014
Q4
$1.44M Sell
17,813
-11,842
-40% -$935K 0.03% 703
2014
Q3
$2.22M Sell
29,655
-1,107
-4% -$80.5K 0.04% 576
2014
Q2
$2.11M Buy
30,762
+1,953
+7% +$133K 0.03% 648
2014
Q1
$2.02M Buy
28,809
+2,228
+8% +$155K 0.03% 625
2013
Q4
$1.78M Buy
26,581
+13,292
+100% +$812K 0.03% 616
2013
Q3
$693K Buy
13,289
+712
+6% +$36.2K 0.01% 768
2013
Q2
$594K Buy
+12,577
New +$574K 0.01% 779

Other funds holding CAH

Natixis Advisors's CAH Position: Q2 2026 in Review

Natixis Advisors reduced its Cardinal Health (CAH) stake by 18% in Q2 2026, selling an estimated $18.8M and leaving 402,374 shares worth $95.6M. The position accounts for 0.11% of the portfolio, ranked #180.

Natixis Advisors first reported a position in CAH in Q2 2013 and has held it in 53 quarters since. The position peaked at $107M in Q4 2025. 1,490 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Natixis Advisors held 402,374 shares of Cardinal Health worth $95.6M as of Q2 2026.
  • Natixis Advisors sold 90,458 Cardinal Health shares in Q2 2026, an estimated $18.8M.
  • Cardinal Health made up 0.11% of Natixis Advisors's portfolio in Q2 2026, its #180 holding.
  • Natixis Advisors first reported a position in Cardinal Health in Q2 2013 and has held it in 53 quarters since.
  • Natixis Advisors's Cardinal Health position peaked at $107M in Q4 2025.
  • 1,490 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Natixis Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.